Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)
托珠单抗治疗慢性活动性抗体介导的排斥反应:一项正在进行的随机对照开放标签多中心试验(INTERCEPT 研究)的原理和方案
期刊:Trials
影响因子:2
doi:10.1186/s13063-024-08020-0
Streichart, Lillian; Felldin, Marie; Ekberg, Jana; Mjörnstedt, Lars; Lindnér, Per; Lennerling, Annette; Bröcker, Verena; Mölne, Johan; Holgersson, Jan; Daenen, Kristien; Wennberg, Lars; Lorant, Tomas; Baid-Agrawal, Seema